Answer
It is licensed for treating and preventing recurrent venous thromboembolism in children, but the formulation must be appropriate for the child's age and swallowing ability.
Sources for this answer
- Dabigatran etexilate 110 mg Hard Capsulesemc · SmPC Current selected SmPC · Version 1